Advertisement Sanofi-Aventis' extended release sleeping pill available in US - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Sanofi-Aventis’ extended release sleeping pill available in US

Sanofi-Aventis' Ambien CR, an extended-release formulation of the popular prescription sleep aid Ambien, is now available by prescription in pharmacies across the US for the treatment of insomnia.

Ambien CR is non-narcotic and a non- benzodiazepine, formulated to offer a similar safety profile to Ambien with a new indication for sleep maintenance, in addition to sleep induction. In contrast to Ambien, Ambien CR is not limited to the short-term treatment of insomnia.

According to a recent National Sleep Foundation poll, more than one half (54%) of Americans said they experience at least one symptom of insomnia at least a few nights a week. In fact, one in five adults experienced difficulty falling asleep and one in three reported waking often during the night at least a few nights a week.

Ambien CR is a bi-layered tablet delivered in two stages. The first layer dissolves quickly to induce sleep. The second layer is released more gradually into the body to help provide more continuous sleep.